Where does Axolabs GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Axolabs GMBH ranks #38,993 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Axolabs GMBH hold?

Axolabs GMBH holds 6 US utility patents granted between 2015 and 2020, spanning 5 technology areas.

What is Axolabs GMBH's Innovation Score?

Axolabs GMBH has an Innovation Score of 24.4 out of 100 (15th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Axolabs GMBH focus on?

Axolabs GMBH's top technology area is C07D (Heterocyclic Compounds) with 4 patents. Grants appear in 5 CPC subclasses total.

Is Axolabs GMBH's patent grant rate increasing or decreasing?

Axolabs GMBH's recent grant velocity is -80% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Axolabs GMBH's patents?

Axolabs GMBH's patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Axolabs GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Axolabs GMBH

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Axolabs ranks #38,993 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#38,993
of 49,997 US assignees by volume: 15th percentile
by Innovation Score (24.4/100): 16.3
avg claims per patent: -80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38993 · Foreign Corporation #38,993 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #38,993/49,997
PHOTO-FINISH AVM Biotechnology
CPC-NARROW C07D · 5 areas
INNOV-THIN 24.4/100
CLAIMS-RICH 16.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AVM Biotechnology, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Axolabs · this assignee

24
3D Lighting… · lowest

7

What this shows Axolabs's Innovation Score is 24.4/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Axolabs's grants concentrate

Axolabs GMBH is a focused PatentsView assignee: 5 CPC subclasses with 66.7% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Axolabs sits between AVM Biotechnology, LLC and Azitra Inc..

AVM Biotechnology

6
AVS Ingenieur J C…

6
AWE

6
Axiomed

6
Axon Vibe

6
AXT

6
Axxana (Israel)

6
Azitra

6
Axolabs ◀

6

What this shows Axolabs holds 6 patents at rank #38,752, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Axolabs

By rank, the assignees closest to #38,752 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Axolabs's primary technology class.

Axolabs's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 15th percentile higher than 15% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Axolabs GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2016	2	33.3%
2017	1	16.7%
2019	1	16.7%
2020	1	16.7%

Which technologies does Axolabs GMBH patent most?

C07D - Heterocyclic Compounds 4

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 4

C07C - Acyclic OR Carbocyclic Compounds 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#38,993

of 49,997 tracked assignees

Innovation Score

24.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Axolabs GMBH's patent record in context - here's where to go next.

Axolabs GMBH's lead technology class is C07D (Heterocyclic Compounds), 66.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #38,993 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Axolabs GMBH against AVM Biotechnology, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.